Point72 Hong Kong LTD Veracyte, Inc. Transaction History

Point72 Hong Kong LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$19.72 - $28.68 $47,328 - $68,832	2,400 New	2,400 $66,000
Q2 2022 Aug 15, 2022	SELL	$15.45 - $29.52 $18,756 - $35,837	-1,214 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$21.94 - $42.51 $26,635 - $51,607	1,214 New	1,214 $33,000
Q4 2021 Feb 14, 2022	SELL	$36.09 - $53.79 $43,632 - $65,032	-1,209 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$35.62 - $52.97 $82,745 - $123,049	-2,323 Reduced 65.77%	1,209 $56,000
Q2 2021 Aug 16, 2021	BUY	$32.94 - $56.62 $112,885 - $194,036	3,427 Added 3263.81%	3,532 $141,000
Q1 2021 May 17, 2021	SELL	$44.47 - $81.38 $94,854 - $173,583	-2,133 Reduced 95.31%	105 $6,000
Q4 2020 Feb 16, 2021	BUY	$32.49 - $61.88 $72,712 - $138,487	2,238 New	2,238 $110,000
Q4 2018 Feb 14, 2019	SELL	$9.15 - $14.85 $5,599 - $9,088	-612 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$9.55 - $12.64 $5,844 - $7,735	612 New	612 $6,000

311

82M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.14B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.